<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1803257092
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2009
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        NEORIN 5MG F.C. TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DESLORATADINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        25.9
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SPIMACO" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 488]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SPIMACO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SPIMACO ADDWAEIH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        R06AX27
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Neorin is</strong><br />Neorin contains desloratadine which is an antihistamine.<br /><strong>How Neorin works</strong><br />Neorin is an antiallergy medicine that does not make you drowsy. It helps control your allergic reaction and its symptoms.<br /><strong>When Neorin should be used</strong><br />Neorin relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults and adolescents 12 years of age and older. These symptoms include sneezing, runny or itchy nose, itchy palate, and itchy, red or watery eyes.<br />Neorin is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). These symptoms include itching and hives.</p><p>Relief of these symptoms lasts a full day and helps you to resume your normal daily activities and sleep.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Neorin</strong><br />- If you are allergic to desloratadine, or any of the other ingredients of this medicine (listed in section 6) or to loratadine.Warnings and precautions<br /><strong>Talk to your doctor, pharmacist or nurse before taking Neorin:</strong><br />- If you have poor kidney function.<br />- If you have medical or familial history of seizures.<br /><strong>Use in children and adolescents</strong><br />Do not give this medicine to children less than 12 years of age.<br /><strong>Other medicines and Neorin</strong><br />There are no known interactions of Neorin with other medicines.<br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.<br /><strong>Neorin with food and drink</strong><br />Neorin may be taken with or without a meal.<br />Use caution when taking Neorinwith alcohol.<br /><strong>Pregnancy, breast-feeding and fertility</strong><br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor, or pharmacist for advice before taking this medicine.<br />Taking Neorin is not recommended if you are pregnant or nursing a baby.<br /><strong>Fertility</strong><br />There is no data available on male/female fertility.<br /><strong>Driving and using machines</strong><br />At the recommended dose, this medicine is not expected to affect your ability to drive or use machines. Although most people do not experience drowsiness, it is recommended not to engage</p><p>in activities requiring mental alertness, such as driving a car or operating machinery until you have established your own response to the medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.<br /><strong>Adults and adolescents 12 years of age and over</strong><br />The recommended dose is one tablet once a day with water, with or without food.<br />This medicine is for oral use.<br />Swallow the tablet whole.<br />Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Neorin.<br />If your allergic rhinitis is intermittent (presence of symptoms for less than 4 days per week or for less than 4 weeks), your physician will recommend you a treatment schedule that will depend on the evaluation of the history of your disease.If your allergic rhinitis is persistent (presence of symptoms for 4 days or more per week and for more than 4 weeks), your physician may recommend you a longer term treatment.<br />For urticaria, the duration of treatment may be variable from patient to patient and therefore you should follow the instructions of your physician.<br /><strong>If you take more Neorin than you should</strong><br />Take Neorin only as it is prescribed for you. No serious problems are expected with accidental overdose. However, if you take more Neorin than you were told to, tell your doctor, pharmacist or nurse immediately.<br /><strong>If you forget to take Neorin</strong><br />If you forget to take your dose on time, take it as soon as possible and then go back to your regular dosing schedule. Do not take a double dose to make up for a forgotten dose.<br />If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.<br /><strong>If you stop taking Neorin</strong></p><p>If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />During the marketing of Neorin, cases of severe allergic reactions (difficulty in breathing, wheezing, itching, hives and swelling) have been reported very rarely. If you notice any of these serious side effects, stop taking the medicine and seek urgent medical advice straight away.<br />In clinical studies in adults, side effects were about the same as with a dummy tablet. However, fatigue, dry mouth and headache were reported more often than with a dummy tablet. In adolescents, headache was the most commonly reported side effect.<br />In clinical studies with Neorin, the following side effects were reported as:<br /><strong>Common: the following may affect up to 1 in 10 people</strong><br />● Fatigue<br />● Dry mouth<br />● Headache<br />During the marketing of Neorin, the following side effects were reported as:<br /><strong>Very rare: the following may affect up to 1 in 10,000 people</strong><br />● Severe allergic reactions<br />● Rash<br />● Pounding or irregular heartbeat<br />● Fast heartbeat<br />● Stomach ache<br />● Feeling sick (nausea)<br />● Vomiting<br />● Upset stomach<br />● Diarrhoea<br />● Dizziness<br />● Drowsiness<br />● Inability to sleep</p><p>● Muscle pain<br />● Hallucinations<br />● Seizures<br />● Restlessness with increased<br />● Liver inflammation<br />● Abnormal liver function tests body movement<br /><strong>Not known: frequency cannot be estimated from the available data</strong><br />●unusual weakness<br />●increased sensitivity of the skin to the sun, even in case of hazy sun, and to UV light, for instance to UV lights of a solarium<br />●changes in the way the heart beats<br />●abnormal behaviour<br />●aggression<br />●weight increased, increased appetite<br />●yellowing of the skin and/or eyes<br /><u>Children</u><br />Not known: frequency cannot be estimated from the available data<br />●slow heartbeat<br />●abnormal behaviour<br />●change in the way the heart beats<br />●aggression<br /><strong>Reporting of side effects</strong><br />If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the carton and blister after EXP.<br />The expiry date refers to the last day of that month.<br />Store below 30&deg;C<br />Store in the original package.<br />Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- The active substance is desloratadine 5 mg<br />- The other ingredients of the tablet are Maize Starch, Starch 1500, Avicel pH 101, Meglumine, Avicel pH 112, Colloidal Silicon Dioxide, Sodium Stearyl Fumarate, Opadry II Blue 32B10817, and Purified Water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Neorin 5 mg film-coated tablets are blue, round biconvex, plain on both sides.
Each pack contains 10 tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>SPIMACO<br />Al-Qassim pharmaceutical plant<br />Saudi Pharmaceutical Industries &amp;<br />Medical Appliance Corporation<br />Saudi Arabia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                February 2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>نيورين يحتوي على ديسلوراتادين وهي مادة مضادة للهيستامين.<br /><strong>كيف يعمل نيورين</strong><br />نيورين هو دواء مضاد للحساسية لا يجعلك نعسان. و هو يساعد للسيطرة على أعراض الحساسية الخاصة بك.<br /><strong>متى ينبغي استخدام نيورين</strong><br />يخفف نيورين من الأعراض المصاحبة لحساسیة الأنف (التهاب في الممرات الأنفیة التي تسببھا الحساسية، على سبيل&nbsp;المثال،<br />حمى القش أو حساسية من ذرات الغبار) في البالغين والمراهقين من عمر 12 سنة أو أكبر. وتشمل هذه الأعراض العطس،<br />سيلان و حكة الأنف ، حكة في الحلق، وحكة وإحمر أو دمع العينين.<br />يستخدم نيورين أيضا لتخفيف الأعراض المرتبطة بالشرى (حالة الجلد الناجم عن حساسية). وتشمل هذه الأعراض حكة<br />والشرى.<br />تخفيف هذه الأعراض تستمر ليوم كامل ويساعدك على استئناف الأنشطة اليومية العادية والنوم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>لا تتناول نيورين</strong><br />- إذا كان لديك حساسية من ديسلوراتادين ، أو أي من المكونات الأخرى من هذا الدواء (المذكورة في الفقرة 6) أو لوراتادين.<br /><strong>تحدث إلى طبيبك أو الصيدلي أو الممرضة قبل تناول نيورين:</strong></p><p>- إذا كان لديك ضعف وظائف الكلى.<br />- إذا كان لديك تاريخ طبي أو عائلي من النوبات.<br /><strong>الاستخدام في الأطفال والمراھقین</strong><br />لا تعطي هذا الدواء للأطفال أقل من 12 سنة من العمر.<br /><strong>تناول أدویة أخرى</strong><br />لا توجد تفاعلات معروفة ل نيورين مع الأدوية الأخرى.<br />أخبر طبيبك أو الصيدلي إذا كنت تتناول، أو تناولت مؤخرا أو قد تتناول أي أدوية أخرى.<br /><strong>تناول نیورین مع الطعام والشراب</strong><br />یمكن تناول نيورين مع أو بدون طعام.<br />توخي الحذر عند تناول نيورين مع الكحول.<br /><strong>الحمل، والرضاعة الطبیعیة والخصوبة</strong><br />إذا كنت حاملا أو ترضعين طفلك طبيعيا، أو تعتقدين أنكى حاملا أو تخططين لإنجاب طفل، إسألى طبيبك أو الصيدلي للحصول<br />على المشورة قبل تناول هذا الدواء.<br />لا ينصح بتناول نيورين إذا كنتى حاملا أو ترضعين طفلك طبيعيا.<br /><strong>الخصوبة</strong><br />لا توجد بيانات متاحة على خصوبة الذكور / الإناث.<br /><strong>القیادة واستخدام الآلات</strong><br />في الجرعة الموصى بها، لیس من المتوقع أن يؤثر هذا الدواء على قدرتك على القيادة أو استخدام الآلات. على الرغم من أن<br />معظم الناس لا يشتكوا من النعاس، فمن المستحسن عدم الانخراط في الأنشطة التي تتطلب اليقظة العقلية، مثل قيادة السيارة أو<br />تشغيل الآلات حتى كنت قد أنشئت استجابة الخاصة بك على المنتج الدوائي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تناول هذا الدواء تماما كما أخبرك طبيبك أو الصيدلي. تأكد من طبيبك أو الصيدلي إذا كنت غير متأكد.<br /><strong>البالغين والمراهقين من 12 سنة وأكثر</strong><br />الجرعة الموصى بها هي قرص واحد مرة واحدة في اليوم مع الماء، مع أو بدون الطعام.</p><p>هذا الدواء هو للاستخدام عن طريق الفم.<br />ابتلع قرص بأكمله.<br />بخصوص مدة العلاج، سوف يحدد الطبيب نوع حساسية الأنف التى تعاني منها وسوف يحدد إلى متى يجب أن تتناول نيورين.<br />إذا كانت حساسية الأنف لديك متقطعة (وجود الأعراض لأقل من 4 أيام في الأسبوع أو لأقل من 4 أسابيع)، فإن طبيبك سوف<br />ينصح بجدول علاج يعتمد على تقييم تاريخ مرضك. إذا كانت حساسية الأنف لديك مستمرة (وجود أعراض لمدة 4 أيام أو أكثر<br />في الأسبوع، وأكثر من 4 أسابيع)، قد يوصي لك الطبيب العلاج على المدى الطویل.<br />فى حالة الشرى،مدة العلاج قد تتغير من مريض لآخر، وبالتالي يجب اتباع تعليمات الطبيب المعالج.<br /><strong>إذا تناولت نيورين أكثر مما ينبغى</strong><br />تناول نيورين فقط كما وصف لك. ومن غير المتوقع حدوث أي مشاكل خطيرة مع الجرعة الزائدة العرضية. ومع ذلك، إذا<br />كنت تناولت نيورين أكثر مما وصف لك، أخبر طبيبك أو الصيدلي أو الممرضة على الفور.<br /><strong>إذا نسيت تناول نيورين</strong><br />إذا كنت قد نسيت أن تأخذ جرعة في الوقت المحدد، تناولها في أقرب وقت ممكن ومن ثم العودة الى الجدول الزمني الاعتيادي<br />الخاص بك. لا تتناول جرعة مضاعفة لتعويض الجرعة المنسية.<br />إذا كان لدیك أي أسئلة أخرى عن استخدام هذا الدواء، اسأل طبيبك أو الصيدلي أو الممرضة.<br /><strong>إذا توقفت عن تناول نيورين</strong><br />إذا كان لديك أي أسئلة أخرى عن استخدام هذا الدواء، اسأل طبيبك أو الصيدلي أو الممرضة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جميع الأدوية، یمكن لهذا الدواء أن يسبب أعراض جانبية، وإن لم تكن تحدث للجمیع.<br />خلال تسويق نيورين ، تم الإبلاغ عن حالات الحساسية الشديدة (صعوبة في التنفس والصفير عند التنفس، وحكة، وخلايا<br />النحل، وتورم) بشكل نادر جدا. إذا لاحظت أي من هذه الأعراض الجانبية الخطيرة، توقف عن تناول الدواء والتمس المشورة<br />الطبية العاجلة على الفور.<br />في الدراسات السريرية في البالغين، كانت الأعراض الجانبیة كما هو الحال مع الأقراص الوهمية. ومع ذلك، تم الإبلاغ عن<br />التعب، جفاف الفم والصداع في كثير من الأحيان مع الأقراص الوهمية. في المراهقين، كان الصداع أكثر الأعراض الجانبية<br />شيوعا.<br />في الدراسات السريرية مع نيورين ، تم الإبلاغ عن الأعراض الجانبية التالية على النحو التالي:<br /><strong>شائع: التالي قد يؤثر على ما يصل إلى 1 في 10 أشخاص</strong><br />التعب ●<br />جفاف الفم ●<br />الصداع ●<br />خلال تسويق نيورين ، تم الإبلاغ عن الأعراض الجانبية التالية على النحو التالي:<br /><strong>نادر جدا: التالية قد يؤثر على ما يصل إلى 1 في 10000 شخص</strong><br />الحساسية الشديدة ●<br />طفح ●<br />طرق أو عدم انتظام ضربات القلب ●<br />ضربات القلب السريعة ●</p><p>آلام المعدة ●<br />الشعور بالمرض (الغثيان) ●<br />القيء ●<br />اضطراب في المعدة ●<br />الإسهال ●<br />الدوخة ●<br />النعاس ●<br />عدم القدرة على النوم ●<br />ألم العضلات ●<br />الهلوسة ●<br />النوبات ●<br />الأرق مع زيادة حركة الجسم ●<br />التهاب الكبد ●<br />خلل غير طبيعى فى اختبارات وظائف الكبد ●<br /><strong>غیر معروف: لا يمكن تقدير تردد من البيانات المتاحة</strong><br />ضعف غير عادي ●<br />زيادة حساسية الجلد لأشعة الشمس، حتى في حالة ضبابية الشمس، والأشعة فوق البنفسجية، على سبيل المثال لأضواء الأشعة ●<br />فوق البنفسجية فى الحمام الشمسي<br />تغييرات في طريقة دق القلب ●<br />سلوك غير طبيعي ●<br />العدوان ●<br />زیادة الوزن، وزيادة الشهية ●<br />اصفرار الجلد و / أو العينين ●<br /><u>الأطفال</u><br />غیر معروف: لا یمكن تقدیر تردد من البیانات المتاحة<br />بطء ضربات القلب ●<br />سلوك غير طبيعي ●<br />تغييرات في طريقة دق القلب ●<br />العدوان ●<br /><strong>الإبلاغ عن الأعراض الجانبية</strong><br />إذا لاحظت أن أيا من هذه الأعراض الجانبية أصبح جسيما، أو إذا لاحظت ظهور أى أعراض جانبية لم ترد فى هذه النشرة<br />فإنه يرجى أن تخبر طبيبك المعالج أو الصيدلى الذى تتعامل معه بشأنها.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيدا عن متناول ونظر الأطفال. ●<br />لا تستعمل أقراص نيورين بعد انتهاء تاریخ الصلاحية المدون على العبوة. وتاريخ الإنتهاء يشير إلى أخر يوم فى ●<br />الشهر المذكور.<br />يحفظ في درجة حرارة أقل من 30 درجة مئوية. ●<br />يجب عدم التخلص من الأدوية في مياه المجاري أو قمامة المنزل. اسأل الصيدلي كيف تتخلص من الأدوية التي لم تعد ●<br />بحاجتها. لأن هذه الاعتبارات ستعمل على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>- المادة الفعالة هى 5 ملجم من ديسلوراتادين<br />- المواد الأخرى فى القرص هى: نشا ذرة و نشا 1500 و أفيسيل بى إتش 101 و ميجلومين و أفيسيل بى إتش 112 و سيليكون<br />ثنائى التأكسد الغروى و صوديوم ستياريل فيوماريت و أوبادريل 2 بلو 32 بى 10817 و ماء منقى.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>أقراص نيورين 5 ملجم هى أقراص مغطاة بطبقة رقيقة زرقاء اللون، مستديرة ثنائية التحدب وعادية على كلا الجانبين. تحتوي كل عبوة على 10 أقراص.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>الدوائية<br />مصنع الأدوية بالقصيم<br />الشركة السعودية للصناعات الدوائية و المستلزمات الطبية<br />المملكة العربية السعودية</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            فبراير 2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Neorin® 5 mg film-coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each tablet contains 5 mg desloratadine.
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film-coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Neorin is indicated in adults and adolescents aged 12 years and older for the relief of symptoms<br />associated with:<br />- allergic rhinitis (see section 5.1)<br />- urticaria (see section 5.1)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />Adults and adolescents (12 years of age and over): The recommended dose of Neorin is one<br />tablet once a day.<br />Intermittent allergic rhinitis (presence of symptoms for less than 4 days per week or for less than<br />4 weeks) should be managed in accordance with the evaluation of patient&#39;s disease history and<br />the treatment could be discontinued after symptoms are resolved and reinitiated upon their<br />reappearance.<br />In persistent allergic rhinitis (presence of symptoms for 4 days or more per week and for more<br />than 4 weeks), continued treatment may be proposed to the patients during the allergen exposure<br />periods.<br />Paediatric population<br />There is limited clinical trial efficacy experience with the use of desloratadine in adolescents 12<br />through 17 years of age (see sections 4.8 and 5.1).</p><p>The safety and efficacy of Neorin 5 mg film-coated tablets in children below the age of 12 years<br />have not been established. No data are available.<br />Method of administration<br />Oral use.<br />The dose can be taken with or without food.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance, to any of the excipients listed in section 6.1, or to
loratadine.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the case of severe renal insufficiency, Neorin should be used with caution (see section 5.2).<br />Desloratadine should be administered with caution in patients with medical or familial history of<br />seizures, and mainly young children, being more susceptible to develop new seizures under<br />desloratadine treatment. Healthcare providers may consider discontinuing desloratadine in<br />patients who experience a seizure while on treatment.<br />Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or<br />glucose-galactose malabsorption should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No clinically relevant interactions were observed in clinical trials with desloratadine tablets in<br />which erythromycin or ketoconazole were co-administered (see section 5.1).<br />Paediatric population<br />Interaction studies have only been performed in adults.<br />In a clinical pharmacology trial, Neorin tablets taken concomitantly with alcohol did not<br />potentiate the performance impairing effects of alcohol (see section 5.1). However, cases of<br />alcohol intolerance and intoxication have been reported during post-marketing use. Therefore,<br />caution is recommended if alcohol is taken concomitantly.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />A large amount of data on pregnant women (more than 1,000 pregnancy outcomes) indicate no<br />malformative nor foeto/ neonatal toxicity of desloratadine. Animal studies do not indicate direct&nbsp;or indirect harmful effects with respect to reproductive toxicity (see section 5.3). As a<br />precautionary measure, it is preferable to avoid the use of Neorin during pregnancy.<br />Breast-feeding<br />Desloratadine has been identified in breastfed newborns/infants of treated women. The effect of<br />desloratadine on newborns/infants is unknown. A decision must be made whether to discontinue<br />breast-feeding or to discontinue/abstain from Neorin therapy taking into account the benefit of<br />breast feeding for the child and the benefit of therapy for the woman.<br />Fertility<br />There are no data available on male and female fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Neorin has no or negligible influence on the ability to drive and use machines based on clinical<br />trials. Patients should be informed that most people do not experience drowsiness. Nevertheless,<br />as there is individual variation in response to all medicinal products, it is recommended that<br />patients are advised not to engage in activities requiring mental alertness, such as driving a car or<br />using machines, until they have established their own response to the medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Summary of the safety profile<br />In clinical trials in a range of indications including allergic rhinitis and chronic idiopathic<br />urticaria, at the recommended dose of 5 mg daily, undesirable effects with Neorin were reported<br />in 3 % of patients in excess of those treated with placebo. The most frequent of adverse reactions<br />reported in excess of placebo were fatigue (1.2 %), dry mouth (0.8 %) and headache (0.6 %). In a<br />clinical trial with 578 adolescent patients, 12 through 17 years of age, the most common adverse<br />event was headache; this occurred in 5.9 % of patients treated with desloratadine and 6.9 % of<br />patients receiving placebo.<br />Paediatric population<br />In a clinical trial with 578 adolescent patients, 12 through 17 years of age, the most common<br />adverse event was headache; this occurred in 5.9 % of patients treated with desloratadine and 6.9<br />% of patients receiving placebo.<br />Tabulated list of adverse reactions<br />The frequency of the clinical trial adverse reactions reported in excess of placebo and<br />other undesirable effects reported during the post-marketing period are listed in the</p><p>following table. Frequencies are defined as very common (&ge; 1/10), common (&ge; 1/100 to<br />&lt; 1/10), uncommon (&ge; 1/1,000 to &lt; 1/100), rare (&ge; 1/10,000 to &lt; 1/1,000), very rare (&lt;<br />1/10,000) and not known (cannot be estimated from the available data).</p><table border="1" cellspacing="1" cellpadding="1" style="width:565px"><tbody><tr><td style="width:178px"><strong>System Organ Class </strong></td><td style="width:147px"><strong>Frequency</strong></td><td style="width:238px"><strong>Adverse reactions seen with Neorin</strong></td></tr><tr><td style="width:178px">Psychiatric disorders</td><td style="width:147px">Very rare</td><td style="width:238px">Hallucinations</td></tr><tr><td style="width:178px">Nervous system<br />disorders</td><td style="width:147px"><p>Common</p><p>&nbsp;</p><p>Very rare</p><p>&nbsp;</p></td><td style="width:238px"><p>Headache</p><p>&nbsp;</p><p>Dizziness, somnolence, insomnia, psychomotor<br />hyperactivity, seizures</p></td></tr><tr><td style="width:178px">Cardiac disorders</td><td style="width:147px">Very rare</td><td style="width:238px">Tachycardia, palpitations</td></tr><tr><td style="width:178px">Gastrointestinal<br />disorders</td><td style="width:147px"><p>Common</p><p>&nbsp;</p><p>Very rare</p><p>&nbsp;</p></td><td style="width:238px"><p>Dry mouth</p><p>&nbsp;</p><p>Abdominal pain, nausea, vomiting, dyspepsia, diarrhoea</p></td></tr><tr><td style="width:178px">Hepatobiliary disorders</td><td style="width:147px">Very rare</td><td style="width:238px">Elevations of liver enzymes, increased bilirubin,</td></tr><tr><td style="width:178px">Skin and subcutaneous skin disorders</td><td style="width:147px">Not known</td><td style="width:238px">Photosensitivity</td></tr><tr><td style="width:178px">Musculoskeletal and<br />connective tissue disorders</td><td style="width:147px">Very rare</td><td style="width:238px">Myalgia</td></tr><tr><td style="width:178px">General disorders and<br />administration site<br />conditions</td><td style="width:147px"><p>Common</p><p>&nbsp;</p><p>Very rare</p><p>&nbsp;</p><p>&nbsp;</p></td><td style="width:238px"><p>Fatigue</p><p>&nbsp;</p><p>Hypersensitivity reactions (such as anaphylaxis,<br />angioedema, dyspnoea, pruritus, rash, and urticaria)</p></td></tr></tbody></table><p>Paediatric population<br />Other undesirable effects reported during the post-marketing period in paediatric patients with an<br />unknown frequency included QT prolongation, arrhythmia, bradycardia, abnormal behaviour,<br />and aggression.</p><p>Reporting of suspected adverse reactions</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>To report any side effect(s):</strong></p><p>The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>o Fax: +966-11-205-7662</p><p>o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.</p><p>o Toll free phone: 8002490000</p><p>o E-mail: npc.drug@sfda.gov.sa</p><p>o Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The adverse event profile associated with overdosage, as seen during post-marketing use, is<br />similar to that seen with therapeutic doses, but the magnitude of the effects can be higher.<br />Treatment<br />In the event of overdose, consider standard measures to remove unabsorbed active substance.<br />Symptomatic and supportive treatment is recommended.<br />Desloratadine is not eliminated by haemodialysis; it is not known if it is eliminated by peritoneal<br />dialysis.<br />Symptoms<br />Based on a multiple dose clinical trial, in which up to 45 mg of desloratadine was administered<br />(nine times the clinical dose), no clinically relevant effects were observed.<br />Paediatric population<br />The adverse event profile associated with overdosage, as seen during post-marketing use, is<br />similar to that seen with therapeutic doses, but the magnitude of the effects can be higher.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: antihistamines &ndash; H1 antagonist, ATC code: R06A X27<br /><u>Mechanism of action</u><br />Desloratadine is a non-sedating, long-acting histamine antagonist with selective peripheral H1-<br />receptor antagonist activity. After oral administration, desloratadine selectively blocks peripheral<br />histamine H1-receptors because the substance is excluded from entry to the central nervous<br />system.</p><p>Desloratadine has demonstrated antiallergic properties from in vitro studies. These include<br />inhibiting the release of proinflammatory cytokines such as IL-4, IL-6, IL-8, and IL-13 from<br />human mast cells/basophils, as well as inhibition of the expression of the adhesion molecule Pselectin<br />on endothelial cells. The clinical relevance of these observations remains to be<br />confirmed.<br /><u>Clinical efficacy and safety</u><br />In a multiple dose clinical trial, in which up to 20 mg of desloratadine was administered daily for<br />14 days, no statistically or clinically relevant cardiovascular effect was observed. In a clinical<br />pharmacology trial, in which desloratadine was administered at a dose of 45 mg daily (nine times<br />the clinical dose) for ten days, no prolongation of QTc interval was seen.<br />No clinically relevant changes in desloratadine plasma concentrations were observed in multipledose<br />ketoconazole and erythromycin interaction trials.<br />Desloratadine does not readily penetrate the central nervous system. In controlled clinical trials,<br />at the recommended dose of 5 mg daily, there was no excess incidence of somnolence as<br />compared to placebo. Neorin given at a single daily dose of 7.5 mg did not affect psychomotor<br />performance in clinical trials. In a single dose study performed in adults, desloratadine 5 mg did<br />not affect standard measures of flight performance including exacerbation of subjective<br />sleepiness or tasks related to flying.<br />In clinical pharmacology trials, co-administration with alcohol did not increase the alcoholinduced<br />impairment in performance or increase in sleepiness. No significant differences were<br />found in the psychomotor test results between desloratadine and placebo groups, whether<br />administered alone or with alcohol.<br />In patients with allergic rhinitis, Neorin was effective in relieving symptoms such as sneezing,<br />nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate.<br />Neorin effectively controlled symptoms for 24 hours. The efficacy of Neorin tablets has not been<br />clearly demonstrated in trials with adolescent patients 12 through 17 years of age.<br /><u>Paediatric population</u><br />The efficacy of Neorin tablets has not been clearly demonstrated in trials with adolescent patients<br />12 through 17 years of age.<br />In addition to the established classifications of seasonal and perennial, allergic rhinitis can<br />alternatively be classified as intermittent allergic rhinitis and persistent allergic rhinitis according<br />to the duration of symptoms. Intermittent allergic rhinitis is defined as the presence of symptoms<br />for less than 4 days per week or for less than 4 weeks. Persistent allergic rhinitis is defined as the<br />presence of symptoms for 4 days or more per week and for more than 4 weeks.</p><p>Neorin was effective in alleviating the burden of seasonal allergic rhinitis as shown by the total<br />score of the rhino-conjunctivitis quality of life questionnaire. The greatest amelioration was seen<br />in the domains of practical problems and daily activities limited by symptoms.<br />Chronic idiopathic urticaria was studied as a clinical model for urticarial conditions, since the<br />underlying pathophysiology is similar, regardless of etiology, and because chronic patients can<br />be more easily recruited prospectively. Since histamine release is a causal factor in all urticarial<br />diseases, desloratadine is expected to be effective in providing symptomatic relief for other<br />urticarial conditions, in addition to chronic idiopathic urticaria, as advised in clinical guidelines.<br />In two placebo-controlled six week trials in patients with chronic idiopathic urticaria, Neorin was<br />effective in relieving pruritus and decreasing the size and number of hives by the end of the first<br />dosing interval. In each trial, the effects were sustained over the 24 hour dosing interval. As with<br />other antihistamine trials in chronic idiopathic urticaria, the minority of patients who were<br />identified as non-responsive to antihistamines was excluded. An improvement in pruritus of<br />more than 50 % was observed in 55 % of patients treated with desloratadine compared with 19 %<br />of patients treated with placebo. Treatment with Neorin also significantly reduced interference<br />with sleep and daytime function, as measured by a four-point scale used to assess these variables.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Absorption</u><br />Desloratadine plasma concentrations can be detected within 30 minutes of administration.<br />Desloratadine is well absorbed with maximum concentration achieved after approximately 3<br />hours; the terminal phase half-life is approximately 27 hours. The degree of accumulation of<br />desloratadine was consistent with its half-life (approximately 27 hours) and a once daily dosing<br />frequency. The bioavailability of desloratadine was dose proportional over the range of 5 mg to<br />20 mg.<br />In a pharmacokinetic trial in which patient demographics were comparable to those of the<br />general seasonal allergic rhinitis population, 4 % of the subjects achieved a higher concentration<br />of desloratadine. This percentage may vary according to ethnic background. Maximum<br />desloratadine concentration was about 3-fold higher at approximately 7 hours with a terminal<br />phase half-life of approximately 89 hours. The safety profile of these subjects was not different<br />from that of the general population.<br /><u>Distribution</u><br />Desloratadine is moderately bound (83 % - 87 %) to plasma proteins. There is no evidence of<br />clinically relevant medicine accumulation following once daily dosing of desloratadine (5 mg to<br />20 mg) for 14 days.</p><p><u>Biotransformation</u><br />The enzyme responsible for the metabolism of desloratadine has not been identified yet, and<br />therefore, some interactions with other medicinal products cannot be fully excluded.<br />Desloratadine does not inhibit CYP3A4 in vivo, and in vitro studies have shown that the<br />medicinal product does not inhibit CYP2D6 and is neither a substrate nor an inhibitor of Pglycoprotein.<br /><u>Elimination</u><br />In a single dose trial using a 7.5 mg dose of desloratadine, there was no effect of food (high-fat,<br />high caloric breakfast) on the disposition of desloratadine. In another study, grapefruit juice had<br />no effect on the disposition of desloratadine.<br /><u>Renally impaired patients</u><br />The pharmacokinetics of desloratadine in patients with chronic renal insufficiency (CRI) was<br />compared with that of healthy subjects in one single-dose study and one multiple dose study. In<br />the single-dose study, the exposure to desloratadine was approximately 2 and 2.5-fold greater in<br />subjects with mild to moderate and severe CRI, respectively, than in healthy subjects. In the<br />multiple-dose study, steady state was reached after Day 11, and compared to healthy subjects the<br />exposure to desloratadine was ~1.5-fold greater in subjects with mild to moderate CRI and ~2.5-<br />fold greater in subjects with severe CRI. In both studies, changes in exposure (AUC and Cmax)<br />of desloratadine and 3-hydroxydesloratadine were not clinically relevant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Desloratadine is the primary active metabolite of loratadine. Non-clinical studies conducted with<br />desloratadine and loratadine demonstrated that there are no qualitative or quantitative differences<br />in the toxicity profile of desloratadine and loratadine at comparable levels of exposure to<br />desloratadine.<br />Non-clinical data reveal no special hazard for humans based on conventional studies of safety<br />pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential, toxicity to<br />reproduction and development. The lack of carcinogenic potential was demonstrated in studies<br />conducted with desloratadine and loratadine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The other ingredients of the tablet are Maize Starch, Starch 1500, Avicel pH 101, Meglumine,<br />Avicel pH 112, Colloidal Silicon Dioxide, Sodium Stearyl Fumarate, Opadry II Blue 32B10817,<br />and Purified Water.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.<br />Store in the original package.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Transparent Thermoformed PVC/PE/PVDC reel with hard tempered aluminum foil lid.<br />Each pack contains 10 tablets</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SPIMACO
Al-Qassim pharmaceutical plant
Saudi Pharmaceutical Industries &
Medical Appliance Corporation
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                February 2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>